3.36
-1.47%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shandong Weigao Group Medical Polymer Co
Its shares trade on HKEX under the ticker 1066.HK. It has been listed since 27 February 2004. In the fiscal year to 31 December 2025, it reported revenue of CN¥15.59bn and net income of CN¥1.88bn. At that date it held total assets of CN¥42.00bn and shareholders' equity of CN¥28.09bn.
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 27 Feb 2004
- Employees
- 10,153
- Website
- en.weigaogroup.com ↗
Leadership
Pay as last reported
- Mr. Jing LongExecutive Chairman of the Board, since 2016CN¥8.3m
- Mr. Rinan CongChief Executive Officer, Executive Director, since 2021CN¥4.0m
- Mr. Zhengpeng TangNon-Executive Vice Chairman of the Board
- Mr. Xuefeng WuChief Financial Officer
- Mr. Junqiang LuExecutive Director, Director and General Manager - Shandong Weigao Orthopaedic Device Company Limited, since 2021CN¥1.3m
- Mr. Daoming WangExecutive Director, since 2024
- Ms. Miu Ling WongCompany Secretary
- Mr. Lin ChenNon-Executive Director
- Ms. Xia YanNon-Executive Director
- Mr. Guohui LiNon-Executive Independent DirectorCN¥207,000
- Mr. Qiang LiNon-Executive Independent DirectorCN¥150,000
- Mrs. Hong MengNon-Executive Independent DirectorCN¥150,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 68
- Environment
- 91
- Social
- 41
- Governance
- 70
- Direct emissions (scope 1)
- 2,704.87 t
- Energy emissions (scope 2)
- 99,528.78 t
- Women in the workforce
- 42.59%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shandong Weigao Group Medical Polymer Co Ltd has several strengths that contribute to its success in the market:
Weaknesses
- Despite its strengths, Shandong Weigao Group Medical Polymer Co Ltd also faces certain weaknesses:
Opportunities
- Shandong Weigao Group Medical Polymer Co Ltd can capitalize on the following opportunities:
Threats
- The following threats pose challenges to Shandong Weigao Group Medical Polymer Co Ltd:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.